David A Khan, MD
University of Texas Southwestern Medical Center · Department of Allergy and Immunology, UT Southwestern
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David A Khan, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:30 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06406114 · Optimizing the Diagnostic Approach to Cephalosporin Allergy TestingMassachusetts General Hospital · recruiting · Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity · principal investigator
- N/ANCT00745849 · Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled TrialUniversity of Texas Southwestern Medical Center · completed · Vasomotor Rhinitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)U01AI184071 · NIAID · MAYO CLINIC JACKSONVILLE · PI Kimberly G. Blumenthal, DAVID A KHAN · fiscal years 2024 to 2026Named on NCT06406114
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.